Unlock instant, AI-driven research and patent intelligence for your innovation.

Active scaffold material capable of promoting bone regeneration as well as preparation method and application of active scaffold material

A scaffold material and bone regeneration technology, applied in the field of biomedical materials, can solve the problems of low concentration, chemical cross-linked molecules entering the body, easy dispersion, etc., to achieve improved local concentration, good biocompatibility and biodegradability, good stability

Inactive Publication Date: 2017-10-03
西岭(镇江)医疗科技有限公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, natural stromal cell-derived factors are maintained at low concentrations in the body and are easily diffused
If chemical cross-linking and other methods are used to cross-link it to the scaffold material, although it will increase the local concentration of SDF1α, it will also introduce toxic or harmful chemical cross-linking molecules into the body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Active scaffold material capable of promoting bone regeneration as well as preparation method and application of active scaffold material
  • Active scaffold material capable of promoting bone regeneration as well as preparation method and application of active scaffold material
  • Active scaffold material capable of promoting bone regeneration as well as preparation method and application of active scaffold material

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0074] A method for preparing the demineralized bone matrix scaffold material for promoting bone regeneration provided by the embodiments of the present invention includes:

[0075] Provides a demineralized bone matrix with a porous internal structure;

[0076] The decalcified bone matrix is ​​contacted with a chemokine solution, so that the decalcified bone matrix is ​​loaded with chemokines to form the decalcified bone matrix scaffold material.

[0077] Further, the preparation method includes: combining the collagen binding region with the stromal cell-derived factor by adopting point gene fusion expression method, so as to form the chemokine.

[0078] Further, the preparation method includes: slowly applying the chemokine solution on the decalcified bone matrix, so that the decalcified bone matrix is ​​loaded with chemokines.

[0079] Further, the concentration of the chemokine solution is above 10 nM.

[0080] Further, the preparation method includes: providing allogene...

Embodiment 1

[0089] (1) Preparation method of demineralized bone matrix scaffold material modified with chemokines

[0090] 1) Firstly, the Escherichia coli expression vector of the chemokine is constructed by using the genetic engineering method known in the industry, and the high-purity chemokine is purified and expressed, wherein the chemokine uses SDF1α;

[0091] 2) Secondly, the decalcified bone matrix material is treated with an acid-base method. Specifically, the long bone tissue of the allogeneic source is provided, cut into a suitable size, and then treated in acetone for 48 hours to remove the soft tissue, fat and other substances on the surface. Then wash with double distilled water several times and then process decalcification with 0.6M HCI solution, freeze-dry after final double distilled water washing; Standby after irradiation sterilization again, the decalcified bone matrix that obtains has the internal structure of loose hole (such as Figure 2A-Figure 2B As shown), it ca...

Embodiment 2

[0105] 1. Preparation of demineralized bone matrix scaffold material modified by CBD-SDF1α and characterization of its macroscopic and microscopic structures

[0106] First, the Escherichia coli expression vector of CBD-SDF1α / NAT-SDF1α was constructed by genetic engineering method, and high-purity CBD-SDF1α / NAT-SDF1α was purified and expressed. Secondly, it is to utilize the acid-base method to obtain the decalcified bone matrix material (DMB stent), and it is ready for use after irradiation sterilization (the same as in Example 1, and the appearance can be referred to Figure 2A-Figure 2B ). Under sterile conditions, dissolve 10nM CBD-SDF1α / NAT-SDF1α with 20μl of PBS, and add dropwise and multiple points onto the sheared material. Note that this step should be performed slowly to ensure sufficient biological activity factors. loaded onto demineralized bone matrix scaffold materials such as Figure 7A The loading of CBD-SDF1α / NAT-SDF1α to the demineralized bone matrix scaffo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a demineralized bone matrix scaffold material capable of promoting bone regeneration, wherein the scaffold material consists of a chemotactic factor and a demineralized bone matrix loading the chemotactic factor, wherein the demineralized bone matrix has a loose pore shaped internal structure and is mainly composed of collagen molecules of spatial net-shaped structure; and the chemotactic factor is bonded with the collagen molecules of the demineralized bone matrix. Furthermore, the chemotactic factor is preferably selected from matrix cell derived factors, and in particular preferably selected from a collagen binding domain and the matrix cell derived factors. The invention also discloses a preparation method and an application of the demineralized bone matrix scaffold material. The demineralized bone matrix scaffold material provided by the invention is good in compatibility, safe and non-toxic, and good in stability in sustained release of biological active factors; local concentration of chemotactic molecules in an injury region can be greatly improved, and mobilization from in-vivo stem cells to the bone injury region can be accelerated, so that the bone regeneration is promoted; in addition, sustained release can last for a long time; meanwhile, the scaffold material is easy to prepare; and the scaffold material, as a bone defect transplantation therapy product, can be widely applied.

Description

technical field [0001] The invention relates to a biological scaffold material, in particular to a decalcified bone matrix scaffold material modified with a matrix cell-derived factor having a collagen binding region, a preparation method and application thereof, and belongs to the field of biomedical materials. Background technique [0002] Bone tissue is one of the few tissues and organs with self-regeneration ability. This regeneration ability not only accompanies individual bone development and bone tissue damage repair process, but can still work effectively even after the individual matures. However, when a large area of ​​bone damage occurs, the bone tissue cannot utilize its own regenerative ability to repair and heal. At present, reconstruction after bone tissue injury mainly depends on transplantation, but it will bring many complications and immune rejection. In clinical treatment, autologous bone transplantation is an ideal method, but this method also has many ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/58A61L27/56A61L27/54A61L27/24A61L27/22A61L27/36
CPCA61L27/227A61L27/24A61L27/3608A61L27/365A61L27/54A61L27/56A61L27/58A61L2300/252A61L2430/02C08L89/00C08L89/06
Inventor 戴建武施家佳孙杰
Owner 西岭(镇江)医疗科技有限公司